Irritable bowel syndrome & allied conditions eg, chronic irritable colon, spastic constipation, mucous colitis and spastic colitis. Symptomatic treatment of abdominal pain, cramps, nonspecific diarrhoea & flatulence. GI spasm secondary to organic diseases eg, diverticulitis, gastritis, duodenitis, oesophagitis, cholecystitis, Crohn's disease, ulcerative colitis, peptic ulcer, gallbladder disease, hiatus hernia, GIT inflammation.
Uses of Mebeverine in details
Mebeverine is used to treat irritable bowel syndrome (disorder of the intestines that leads to cramps in the abdomen, gas, bloating and changes in bowel habits). It is also used to treat other conditions that involve spasm and pain related to small and large bowel.
Each capsule contains Mebeverine HCl 200 mg.
Mebeverine also contains the following excipients: Capsule Content (Granules): Magnesium stearate, polyacrylate dispersion 30%, talc, hypromellose, methacrylic acid-ethyl acrylate copolymer (1:1) dispersion 30% and glycerol triacetate. Capsule Shell: Gelatin, titanium dioxide (E171). Printing Ink: Shellac (E904), black iron oxide (E172), propylene glycol, concentrated ammonia solution, potassium hydroxide.
Adults: 1 capsule twice daily (1 in the morning and 1 in the evening).
Special Populations: Elderly, Renal and Hepatic Impairment: No posology studies in elderly, renal and/or hepatically impaired patients have been performed. However, no specific risk for elderly, renal and/or hepatically impaired patients could be identified from available post-marketing data. No dosage adjustment is deemed necessary in these patients.
Missed Dose: In case of ≥1 doses missed, continue with the next dose as prescribed; the missed doses are not to be taken in addition to the regular dose.
Administration: The capsules should be swallowed with a sufficient amount of water (at least 100 mL of water).
It should not be chewed because the coating is intended to ensure a prolonged release mechanism.
No interaction studies have been performed except with alcohol. In vitro and in vivo studies in animals have demonstrated the absence of any interaction between Mebeverine and ethanol.
Incompatibilities: Not applicable.
Mebeverine side effects
Although adverse effects appear rare, gastrointestinal disturbances, dizziness, headache, insomnia, anorexia and tachycardia have been reported in patients receiving Mebeverine.
Hypersensitivity to Mebeverine HCl or to any of the excipients of Mebeverine.
Active ingredient matches for Mebeverine:
|Unit description / dosage (Manufacturer)||Price, USD|
|Capsule; Oral; Mebeverine Hydrochloride 100 mg|
|Capsule; Oral; Mebeverine Hydrochloride 200 mg|
|Tablet, Sugar-Coated; Oral; Mebeverine Hydrochloride 135 mg|
List of Mebeverine substitutes (brand and generic names):
|Mebeverin Solvay (Germany)|
|Mébévérine Biogaran (France)|
|Mébévérine EG (France)|
|Mebeverine EG (Belgium)|
|Mebeverine EG-135 (Luxembourg)|
|Mebeverine HCl Aurobindo Retard (Netherlands)|
|Mebeverine HCl retard (Netherlands)|
|Mebeverine Hydrochloride Fisher (Netherlands)|
|Mébévérine Qualimed (France)|
|Mebeverine Sopharma (Bulgaria)|
|Mébévérine Teva (France)|
|Mébévérine Zentiva (France)|
|Mébévérine Zydus (France)|
|Mebeverinehydrochloride ERC Retard (Netherlands)|
|Mebeverixx Lyssia (Germany)|
|MEBIZ CAPSULE SR 1 strip / 10 capsule srs each (Sun Pharma Laboratories Ltd)||$ 2.37|
|Mebiz 200mg Capsule MR (Sun Pharmaceutical Industries Ltd)||$ 0.26|
|Mebiz SR (Myanmar)|
|Mebiz SR cap 200 mg 10's (Sun Pharma)|
|Mebrin 135mg TAB / 100 (Psycorem)||$ 8.57|
|135 mg x 100's (Psycorem)||$ 8.57|
|MEBRIN tab 135 mg x 10's (Psycorem)||$ 0.86|
|Tablet; Oral; Mebeverine Hydrochloride 135 mg (Medipharm)|
|Tablet, Prolonged Release; Oral; Mebeverine Hydrochloride 200 mg|
|Menosor 135 mg x 3 x 10's (Tp)|
|Mepacolon SR (Egypt)|
|Merck-Mebeverine HCl (South Africa)|
|10's (Zydus (Alidac))|
|200 mg x 10's (Zydus (Alidac))||$ 1.45|
|Meva - SR-TAB / 10 (Zydus (Alidac))|
|Meva 200mg SR-CAP / 10 (Zydus (Alidac))||$ 1.45|
|MEVA CAPSULE SR 1 strip / 10 capsule srs each (Zydus (Alidac))||$ 2.07|
|MEVA SR cap 200 mg x 10's (Zydus (Alidac))||$ 1.72|
|Meva 200mg Capsule SR (Zydus (Alidac))||$ 0.23|
|Meverina 200 S.R. (Paraguay)|
- PubChem. "mebeverine". https://pubchem.ncbi.nlm.nih.gov/com... (accessed September 17, 2018).
- DrugBank. "Mebeverine". http://www.drugbank.ca/drugs/DB12554 (accessed September 17, 2018).
- MeSH. "Parasympatholytics". https://www.ncbi.nlm.nih.gov/mesh/68... (accessed September 17, 2018).
ReviewsThe results of a survey conducted on ndrugs.com for Mebeverine are given in detail below. The results of the survey conducted are based on the impressions and views of the website users and consumers taking Mebeverine. We implore you to kindly base your medical condition or therapeutic choices on the result or test conducted by a physician or licensed medical practitioners.
Consumer reported usefulNo survey data has been collected yet
Consumer reported price estimatesNo survey data has been collected yet
2 consumers reported time for resultsTo what extent do I have to use Mebeverine before I begin to see changes in my health conditions?
As part of the reports released by ndrugs.com website users, it takes > 3 month and a few days before you notice an improvement in your health conditions.
Please note, it doesn't mean you will start to notice such health improvement in the same time frame as other users. There are many factors to consider, and we implore you to visit your doctor to know how long before you can see improvements in your health while taking Mebeverine. To get the time effectiveness of using Mebeverine drug by other patients, please click here.
|> 3 month||1||50.0%|
6 consumers reported age
There are no reviews yet. Be the first to write one!
Information checked by Dr. Sachin Kumar, MD Pharmacology